rs111841420

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001854.4(COL11A1):​c.1872A>G​(p.Pro624Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0225 in 1,610,560 control chromosomes in the GnomAD database, including 491 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 56 hom., cov: 32)
Exomes 𝑓: 0.022 ( 435 hom. )

Consequence

COL11A1
NM_001854.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.199
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 1-103004635-T-C is Benign according to our data. Variant chr1-103004635-T-C is described in ClinVar as [Benign]. Clinvar id is 93967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-103004635-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.199 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0236 (3587/152230) while in subpopulation AMR AF= 0.0252 (386/15296). AF 95% confidence interval is 0.0238. There are 56 homozygotes in gnomad4. There are 1833 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 56 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A1NM_001854.4 linkc.1872A>G p.Pro624Pro synonymous_variant Exon 19 of 67 ENST00000370096.9 NP_001845.3 P12107-1Q59HB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkc.1872A>G p.Pro624Pro synonymous_variant Exon 19 of 67 1 NM_001854.4 ENSP00000359114.3 P12107-1

Frequencies

GnomAD3 genomes
AF:
0.0235
AC:
3577
AN:
152112
Hom.:
55
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0249
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0253
Gnomad ASJ
AF:
0.0254
Gnomad EAS
AF:
0.00578
Gnomad SAS
AF:
0.0176
Gnomad FIN
AF:
0.0468
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0202
Gnomad OTH
AF:
0.0307
GnomAD3 exomes
AF:
0.0242
AC:
6065
AN:
250290
Hom.:
93
AF XY:
0.0237
AC XY:
3214
AN XY:
135408
show subpopulations
Gnomad AFR exome
AF:
0.0256
Gnomad AMR exome
AF:
0.0320
Gnomad ASJ exome
AF:
0.0307
Gnomad EAS exome
AF:
0.00492
Gnomad SAS exome
AF:
0.0192
Gnomad FIN exome
AF:
0.0433
Gnomad NFE exome
AF:
0.0217
Gnomad OTH exome
AF:
0.0290
GnomAD4 exome
AF:
0.0224
AC:
32613
AN:
1458330
Hom.:
435
Cov.:
30
AF XY:
0.0220
AC XY:
15992
AN XY:
725522
show subpopulations
Gnomad4 AFR exome
AF:
0.0270
Gnomad4 AMR exome
AF:
0.0319
Gnomad4 ASJ exome
AF:
0.0290
Gnomad4 EAS exome
AF:
0.00450
Gnomad4 SAS exome
AF:
0.0188
Gnomad4 FIN exome
AF:
0.0426
Gnomad4 NFE exome
AF:
0.0213
Gnomad4 OTH exome
AF:
0.0269
GnomAD4 genome
AF:
0.0236
AC:
3587
AN:
152230
Hom.:
56
Cov.:
32
AF XY:
0.0246
AC XY:
1833
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.0251
Gnomad4 AMR
AF:
0.0252
Gnomad4 ASJ
AF:
0.0254
Gnomad4 EAS
AF:
0.00579
Gnomad4 SAS
AF:
0.0178
Gnomad4 FIN
AF:
0.0468
Gnomad4 NFE
AF:
0.0202
Gnomad4 OTH
AF:
0.0299
Alfa
AF:
0.0218
Hom.:
12
Bravo
AF:
0.0235
Asia WGS
AF:
0.0220
AC:
76
AN:
3478
EpiCase
AF:
0.0246
EpiControl
AF:
0.0225

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Sep 26, 2013
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 03, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:4
May 24, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 30, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Fibrochondrogenesis 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Stickler syndrome type 2 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Connective tissue disorder Benign:1
Apr 01, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
3.1
DANN
Benign
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs111841420; hg19: chr1-103470191; API